Clinical trial
Gefitinib With or Without Tamoxifen in Treating Patients With…
NCT00080743 · Dartmouth-Hitchcock Medical Center, Other · Completed
Key facts
| NCT number | NCT00080743 |
|---|---|
| Title | Gefitinib With or Without Tamoxifen in Treating Patients With Tamoxifen-Resistant Metastatic Breast Cancer |
| Official title | ZD1839 (IRESSA) In Tamoxifen-Resistant Metastatic Breast Cancer |
| Lead sponsor | Dartmouth-Hitchcock Medical Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH Norris Cotton Cancer Center |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | gefitinib, tamoxifen citrate, Placebo |
| Enrollment | 2 |
| Start date | Jan 1, 2004 |
| Primary completion | Apr 1, 2005 |
| Completion | Nov 1, 2005 |
| First posted | Apr 8, 2004 |
| Last update posted | Aug 6, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: